AHSG Thr256Ser Gene Polymorphism as a Predictor of Low Serum Fetuin-A Levels in Indonesian Maintenance Hemodialysis Patients


  • Riri Andri Muzasti Departement of Internal Medicine, Division of Nephrology and Hypertension, Universitas Sumatera Utara, Medan, Indonesia
  • Suhardjono Departement of Internal Medicine, Division of Nephrology and Hypertension, Universitas Sumatera Utara, Medan, Indonesia
  • M. B. Purwanto Departement of Internal Medicine, Division of Nephrology and Hypertension, Universitas Negeri Surakarta, Solo, Indonesia
  • R. J. Sembiring Departement of Clinical Pathology, Universitas Sumatera Utara, Medan, Indonesia




AHSG Thr256Ser gene polymorphism, Fetuin-A, Hemodialysis


BACKGROUND: Vascular calcification (VC) is a risk factor for cardiovascular morbidity and mortality in maintenance hemodialysis (MHD) patients. The effect of alpha2-Heremans Schmid glycoprotein (AHSG) Thr256Ser gene polymorphism toward serum fetuin-A levels as one of the VC inhibitors in MHD patients is still unclear.

OBJECTIVE: This study aims to investigate the relationship between AHSG Thr256Ser gene polymorphism toward serum fetuin-A levels in MHD patients in Indonesia.

METHODS: The research study design used was cross-sectional. Serum fetuin-A levels were assessed by enzyme-linked immunosorbent assay method, and polymerase chain reaction-restriction fragment length polymorphism determined AHSG Thr256Ser gene polymorphism. Multivariate linear regression analysis was used to analyze the factors related to serum fetuin-A levels. p < 0.05 was considered as statistically significant.

RESULTS: Median value of serum fetuin-A levels was 235.0 pg/ml (ranging 78–756) with mean 259.99 ± 119.36 pg/ml. Out of 106 patients involved, the distribution of AHSG Thr256Ser genotype frequency was 54 (50.9%) respondents had CG genotype, 46.2% had CC genotype, and the others (2.8%) had GG genotype. Patients with homozygous C allele (CC genotype) were 0.1 times more protected (CI 95%: 0.1–0.3) to have low serum fetuin-A levels, compared with patients with G allele either in a homozygote (GG genotype) or in the heterozygote (CG genotype). From the multivariate analysis results, it can be obtained a formulation in predicting serum fetuin-A level, which is: Serum fetuin-A level prediction = 276,59 + 150,49 DM - 0,26 serum interleukin -6 level - 43,58 AHSG Thr256Ser gene polymorphism

CONCLUSIONS: AHSG Thr256Ser gene polymorphism had a significant relationship with serum fetuin-A levels in MHD patients in Indonesia. Subjects with G allele (CG and GG genotypes) had lower serum fetuin-A levels than those with CC genotype.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Cozzolino M, Mangano M, Stucchi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33 Suppl 3:iii28- 34. https://doi.org/10.1093/ndt/gfy174 PMid:30281132

Maharem DA, Gomaa SH, Gandhi MK, Mohamed EI. Association of serum fetuin-a and fetuin-a gene polymorphism in relation to mineral and bone disorders in patients with chronic kidney disease. Egyp J Med Hum Genet. 2013;14(4):337-52. https:// doi.org/10.1016/j.ejmhg.2013.07.003

Altuntas A, Yigit A, Uz E, Inal S. The relationship between fetuin levels and fetuin gene polymorphism in a hemodialysis patient. Biomed India. 2017;28(2):495-5. https://doi.org/10.1093/ndt/ gfv199.29

Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits- Filho R, Gao P, et al. Low fetuin-a levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005;67(6):2383-92. https://doi. org/10.1111/j.1523-1755.2005.00345.x PMid:15882283

Axelsson J, Wang X, Ketteler M, Qureshi AR, Heimbürger O, Bárány P. Is fetuin-a/alpha2-heremans-schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease? Am J Nephrol. 2008;28(4):669-76. https://doi. org/10.1159/000121358 PMid:18337634

Cozzolino M, Dusso AS, Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol. 2001;12(11):2511-6. PMid:11675430

Zeidan MA, Sharara GM, Suliman HS, Zeid MM, Zytoun SS, Nomeir HM. Visfatin and fetuin-a: Novel markers for endothelial dysfunction in chronic kidney disease. Life Sci J. 2012;9(2):227-43.

Jensen KM, Jensen RA, Mukamal KJ. Detection of genetic loci associated with plasma fetuin-a: A meta-analysis of genome-wide association studies from the CHARGE consortium. Hum Mol Genet. 2017;26(11):2156-63. PMid:28379451

Verduijn M, Prein RA, Stenvinkel P, Carrero JJ, le Cessie S, Witasp A, et al. Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach. Nephrol Dial Transplant. 2011;26(1):239-45. https:// doi.org/10.1093/ndt/gfq402 PMid:20605840

Trepanowski JF, Mey J, Varady KA. Fetuin-a: A novel link between obesity and related complications. Int J Obes (Lond). 2015;39(5):734-41. https://doi.org/10.1038/ijo.2014.203 PMid:25468829

Celebi G, Genc H, Gurel H, Sertoglu E, Kara M, Tapan S, et al. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease. Saudi J Gastroenterol. 2015;21(3):139-45. https://doi.org/10.4103/1319-3767.157556 PMid:26021772

Sindhu S. Fetuin an (AHSG) in metabolic and inflammatory diseases: A foe or a friend. Diabetes Obes Int J. 2015;1(5):127. https://doi.org/10.23880/doij-16000127

Oikawa O, Higuchi T, Yamazaki T. Evaluation of serum fetuin-a relationships with biochemical parameters in patients on hemodialysis. Clin Exp Nephrol. 2007;11(4):304-8. https://doi. org/10.1007/s10157-007-0499-y PMid:18085392

Ann A, Makkar V, Mann S, Ghamija P, Soundrajan P. Fetuin-a and vascular calcification in Indian end-stage renal disease population. Indian J Nephrol. 2016;26(1):33-8. https://doi. org/10.4103/0971-4065.157007 PMid:26937076

Yamada S, Tokumoto M, Tsuruya K. Fetuin-a induced by low protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Am J Physiol Renal Physiol. 2015;309(8):F744-54. https://doi.org/10.1152/ ajprenal.00017.2015 PMid:26180236




How to Cite

Muzasti RA, Suhardjono S, Purwanto MB, Sembiring RJ. AHSG Thr256Ser Gene Polymorphism as a Predictor of Low Serum Fetuin-A Levels in Indonesian Maintenance Hemodialysis Patients. Open Access Maced J Med Sci [Internet]. 2020 May 5 [cited 2022 Jul. 1];8(A):185-90. Available from: https://oamjms.eu/index.php/mjms/article/view/3520

Most read articles by the same author(s)